Followers | 28 |
Posts | 4490 |
Boards Moderated | 1 |
Alias Born | 09/22/2006 |
Wednesday, March 19, 2008 9:33:50 PM
Three million shares (in round numbers) were bought up in the last two days. I'm not sure, but I don't believe this is all attributable to the index rebalancing. If memory serves, we went through this once before when HALO upliststed and I don't recall the PPS getting much of a pop out of that circumstance despite the fact that many index funds had to purchase HALO. My one dollar bet is placed on R. Kirk entering the market. The fetters are off of him now that we have full disclosure of the pipeline; he no longer has need to worry about insider trading issues. I believe that this is what he has been waiting for. We should see a filing in a couple of days, IMHO.
This is not to say that the new inclusion into these HealthShares(TM) Indices plays no role. It may be a happy coincidence occurring alongside Kirk's determination to round out his position, thus making them compete for the same shares. Add to this the strong possibility that shorts were caught off guard and we may have a substantial rally as I mentioned in my post this morning. I love it that all this is happening just a few days after the Roth and Brean Murray downgrades! I can't wait to see how quickly they have to eat crow and issue an upgrade! LOL!
I give absolutely no weight to any so-called buyout "rumors".
As for the chart: Normally I would agree with Hew in that I would expect a pause or pullback even as early as tomorrow. But that depends upon the needs and intentions of Kirk, HealthShares(TM) Indexes and chasing shorts. Mix in some momo players who are going to pick this up in their scans tonight and I believe that the 200 day moving average is easily attainable. This would put us in the high 7's before a pullback and consolidation. Of course, news trumps all. "Stay tuned"!
Good luck!
-Fritz
The more you know, the less you don't know.
Recent HALO News
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2024 08:05:56 PM
- HALOZYME REPORTS THIRD QUARTER 2024 FINANCIAL AND OPERATING RESULTS • PR Newswire (US) • 10/31/2024 08:01:00 PM
- HALOZYME PROVIDES UPDATE ON LICENSEE CO-FORMULATION PATENT HEARING IN EUROPE • PR Newswire (US) • 10/24/2024 10:30:00 AM
- Halozyme to Report Third Quarter 2024 Financial and Operating Results • PR Newswire (US) • 10/23/2024 08:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/16/2024 10:53:48 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/16/2024 08:14:21 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/15/2024 08:34:07 PM
- ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • InvestorsHub NewsWire • 10/10/2024 12:09:56 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 10/09/2024 09:39:44 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/09/2024 08:09:23 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 10/08/2024 08:08:02 PM
- Halozyme Announces Expansion of Global Collaboration and License Agreement with argenx for ENHANZE® • PR Newswire (US) • 10/03/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/26/2024 10:06:56 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/26/2024 08:05:28 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/25/2024 08:00:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/24/2024 08:05:31 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/18/2024 10:49:57 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/18/2024 08:01:16 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/17/2024 08:03:48 PM
- Halozyme Announces FDA Approval of Roche's Subcutaneous OCREVUS ZUNOVO™ with ENHANZE® for People with Relapsing and Primary Progressive Multiple Sclerosis • PR Newswire (US) • 09/13/2024 05:30:00 PM
- Halozyme Announces FDA Approval of Roche's Tecentriq Hybreza™ With ENHANZE® for Multiple Types of Cancer • PR Newswire (US) • 09/13/2024 12:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 09/12/2024 09:56:59 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/12/2024 08:12:07 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/11/2024 08:05:49 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 09/10/2024 08:16:18 PM
FEATURED DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • Nov 7, 2024 2:16 PM
FEATURED SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • Nov 7, 2024 8:48 AM
FEATURED SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • Nov 7, 2024 7:00 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
VAYK Confirms Insider Buying at Open Market • VAYK • Nov 5, 2024 10:40 AM
Rainmaker Worldwide Inc. Announces Strategic Partnership Between Miranda Water Technologies and Fleming College • RAKR • Nov 4, 2024 12:03 PM